Skip to content

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
  • Home
  • About
    • NIH Collaboratory
      • Coordinating Center
      • NIH Collaboratory Trials
      • Core Working Groups
      • Steering Committee
      • Distributed Research Network
      • Our Impact
    • Living Textbook
      • Table of Contents
      • How to Use This Site
  • Resources
    • Data and Resource Sharing
    • Training Resources
    • Tools for Researchers
    • Publications
    • Knowledge Repository
  • Webinar
  • Podcast
  • News
    • News Feed
    • Calendar
    • Subscribe
return to home
Subscribe to Newsletter go to twitter feed go to linkedin go to blue sky feed
Search
NIH Collaboratory
Living Textbook of
Pragmatic Clinical Trials

COVID-19 Resources

Access the latest information on COVID-19 for clinical researchers
home button

Rethinking Clinical Trials

A Living Textbook of Pragmatic Clinical Trials

  • Design
    • What is a Pragmatic Clinical Trial?
    • Decentralized Pragmatic Clinical Trials
    • Developing a Compelling Grant Application
    • Experimental Designs and Randomization Schemes
    • Endpoints and Outcomes
    • Analysis Plan
    • Using Electronic Health Record Data
    • Building Partnerships and Teams to Ensure a Successful Trial
    • Intervention Delivery and Complexity
    • Patient Engagement
  • Data, Tools & Conduct
    • Assessing Feasibility
    • Acquiring Real-World Data
    • Assessing Fitness-for-Use of Real-World Data
    • Study Startup
    • Participant Recruitment
    • Monitoring Intervention Fidelity and Adaptations
    • Patient-Reported Outcomes
    • Clinical Decision Support
    • Mobile Health
    • Electronic Health Records–Based Phenotyping
    • Navigating the Unknown
  • Dissemination & Implementation
    • Data Sharing and Embedded Research
    • Dissemination Approaches for Different Audiences
    • Implementation
    • End-of-Trial Decision-Making
  • Ethics & Regulatory
    • Privacy Considerations
    • Identifying Those Engaged in Research
    • Collateral Findings
    • Consent, Disclosure, and Non-Disclosure
    • Data and Safety Monitoring
    • Ethical Considerations of Data Sharing in Pragmatic Clinical Trials
    • Ethics for AI and ML
    • IRB Responsibilities and Procedures

Definition of Intervention Complexity

CHAPTER SECTIONS

Intervention Delivery and Complexity


Section 2

Definition of Intervention Complexity

Expand Contributors

Stephen Z. George, PhD, PT

Karen Staman, MS

Contributing Editor

Gina Uhlenbrauck

According to AHRQ, all complex interventions have two common characteristics (Kelly et al. 2017):

  • They have multiple components (intervention related)
  • They have complicated/multiple causal pathways, feedback loops, synergies, and/or mediators and moderators of effect (pathway related)

The NIH has guidance on how to develop complex interventions and has developed a  framework of actions for intervention development (O’Cathain et al. 2019). While the framework is focused on developing complex interventions and not delivering them, some key advice pertains to both, including involving teams that include those who will deliver, use, and benefit from the intervention, and understanding context.

Similarly, PCORI has standards for studies of complex interventions (2015). The key aspects that inform intervention delivery include defining the casual pathway, which involves an understanding of contextual factors that may impact intervention delivery. PCORI requires recipients of its research funding to fulfill the following requirements when designing and conducting studies with complex interventions:

  • Fully describe the intervention of interest and the comparator
  • Define core functions for the intervention and the comparator
  • Specify the hypothesized causal pathways and their theoretical basis
  • Specify how adaptations to the form of the intervention and comparator will be allowed and recorded
  • Plan and describe a process evaluation
  • Select patient outcomes informed by the causal pathway

From the field of Dissemination and Implementation Science, The Practical, Robust, Implementation and Sustainability (PRISM) framework, also emphasizes how contextual factors can impact implementation and sustainability of an intervention (McCreight et al. 2019). Other resources include TIDieR framework, which refers to the types of location where the intervention will be delivered (Hoffmann et al. 2014), and the Context and Implementation of Complex Interventions (CICI) Framework, which describes contextual issues and provides guidance regarding how to understand studies according to their context (Pfadenhauer et al. 2017).

Another tool available for measuring intervention complexity is the Intervention Complexity Assessment Tool (iCAT-SR) (Lewin et al. 2017; Lewin et al.) for use in the context of systematic reviews. After a thorough review of the literature, the NIH Pragmatic Trials Collaboratory team used the iCAT-SR tool as a starting point for identifying key domains of complexity of intervention delivery.  This starting point eventually led to the factors included in the Intervention Delivery Complexity tool, described in the next section.

Previous Section Next Section

SECTIONS

CHAPTER SECTIONS

sections

  1. Introduction
  2. Definition of Intervention Complexity
  3. Intervention Delivery Complexity Tool
  4. Examples of Tool Output

REFERENCES

back to top

Hoffmann TC, Glasziou PP, Boutron I, et al. 2014. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 348:g1687–g1687. doi:10.1136/bmj.g1687.

Kelly MP, Noyes J, Kane RL, et al. 2017. AHRQ series on complex intervention systematic reviews—paper 2: defining complexity, formulating scope, and questions. J Clin Epidemiol. 90:11–18. doi:10.1016/j.jclinepi.2017.06.012.

Lewin S, Hendry M, Chandler J, et al. 2017. Assessing the complexity of interventions within systematic reviews: development, content and use of a new tool (iCAT_SR). BMC Med Res Methodol. 17:76. doi:10.1186/s12874-017-0349-x.

Lewin S, Hendry M, Chandler J, et al. 2016. Guidance for using the iCAT_SR: Intervention Complexity Assessment Tool for Systematic Reviews.Cochrane Methods; 2016. http://methods.cochrane.org/sites/methods.cochrane.org/files/uploads/icat_sr_additional_file_4_2016_12_27.pdf

 

back to top

McCreight MS, Rabin BA, Glasgow RE, et al. 2019. Using the Practical, Robust Implementation and Sustainability Model (PRISM) to qualitatively assess multilevel contextual factors to help plan, implement, evaluate, and disseminate health services programs. Transl Behav Med. 9:1002–1011. doi:10.1093/tbm/ibz085.

O’Cathain A, Croot L, Duncan E, et al. 2019. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 9:e029954. doi:10.1136/bmjopen-2019-029954.

Pfadenhauer LM, Gerhardus A, Mozygemba K, et al. 2017. Making sense of complexity in context and implementation: the Context and Implementation of Complex Interventions (CICI) framework. Implement Sci. 12:21. doi:10.1186/s13012-017-0552-5.


Version History

Published on April 21, 2023

current section :

Definition of Intervention Complexity

  1. Introduction
  2. Definition of Intervention Complexity
  3. Intervention Delivery Complexity Tool
  4. Examples of Tool Output

Citation:

George SZ, Staman K. Intervention Delivery and Complexity: Definition of Intervention Complexity. In: Rethinking Clinical Trials: A Living Textbook of Pragmatic Clinical Trials. Bethesda, MD: NIH Pragmatic Trials Collaboratory. Available at: https://rethinkingclinicaltrials.org/chapters/design/intervention-delivery-and-complexity/definition-of-intervention-complexity/. Updated March 27, 2024. DOI: 10.28929/219.

Footer Menu

  • How to Use This Site
  • About NIH Collaboratory
  • Enrollment Reporting
  • Grand Rounds
  • Funding Statement
Link to Twitter Link to LinkedIn Link to Blue Sky Link to NIH Collaboratory email

Reference in this Web site to any specific commercial products, process, service, manufacturer, or company does not constitute its endorsement or recommendation by the U.S. Government or National Institutes of Health (NIH). NIH is not responsible for the contents of any “off-site” Web page referenced from this server.

Log in
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly. Site Map